Phio Pharmaceuticals Corp... (PHIO)

AI Score

Unlock

1.17

-0.04 (-3.31%)

At close: Apr 03, 2025, 3:59 PM

1.18

0.80%

After-hours: Apr 03, 2025, 07:56 PM EDT

Dividends

No dividend history available for Phio Pharmaceuticals Corp..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

PHIO News

16 hours ago · Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894 - newsfilecorp.com
3 days ago · Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update - newsfilecorp.com
3 weeks ago · American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting - newsfilecorp.com
4 weeks ago · Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study - newsfilecorp.com
1 month ago · Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - newsfilecorp.com
1 month ago · Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors - newsfilecorp.com
2 months ago · Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - newsfilecorp.com
2 months ago · Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - newsfilecorp.com
2 months ago · Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - newsfilecorp.com
2 months ago · Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - newsfilecorp.com